Cargando…
A New Peritoneal Dialysis Solution Containing L-Carnitine and Xylitol for Patients on Continuous Ambulatory Peritoneal Dialysis: First Clinical Experience
Peritoneal dialysis (PD) is a feasible and effective renal replacement therapy (RRT) thanks to the dialytic properties of the peritoneal membrane (PM). Preservation of PM integrity and transport function is the key to the success of PD therapy, particularly in the long term, since the prolonged expo...
Autores principales: | Rago, Carmela, Lombardi, Teresa, Di Fulvio, Giorgia, Di Liberato, Lorenzo, Arduini, Arduino, Divino-Filho, José C., Bonomini, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996173/ https://www.ncbi.nlm.nih.gov/pubmed/33668249 http://dx.doi.org/10.3390/toxins13030174 |
Ejemplares similares
-
Current Opinion on Usage of L-Carnitine in End-Stage Renal Disease Patients on Peritoneal Dialysis
por: Bonomini, Mario, et al.
Publicado: (2019) -
Proteomic Research in Peritoneal Dialysis
por: Bonomini, Mario, et al.
Publicado: (2020) -
The osmo-metabolic approach: a novel and tantalizing glucose-sparing strategy in peritoneal dialysis
por: Bonomini, Mario, et al.
Publicado: (2020) -
Fibrosis of Peritoneal Membrane as Target of New Therapies in Peritoneal Dialysis
por: Masola, Valentina, et al.
Publicado: (2022) -
How to Improve the Biocompatibility of Peritoneal Dialysis Solutions (without Jeopardizing the Patient’s Health)
por: Bonomini, Mario, et al.
Publicado: (2021)